QuantumBind-RBFE: Accurate Relative Binding Free Energy Calculations Using Neural Network Potentials

📅 2025-01-03
📈 Citations: 0
Influential: 0
📄 PDF
🤖 AI Summary
Insufficient accuracy in predicting drug–protein binding affinities hinders computational drug discovery. To address this, we propose a novel relative binding free energy (RBFE) method based on the AceForce 1.0 neural network potential (NNP), the first application of this TensorNet-architecture NNP to RBFE calculations. Our approach supports all chemical elements and charged drug molecules, and enables stable molecular dynamics simulations with a 2-fs time step—over twofold faster than comparable NNPs. On standard benchmark datasets, our method significantly outperforms GAFF2 and ANI2-x, achieving accuracy on par with OPLS4, while maintaining high computational efficiency. The implementation—including source code and pre-trained models—is publicly released. This work establishes a scalable, physics-informed, AI-driven computational paradigm for high-fidelity drug design.

Technology Category

Application Category

📝 Abstract
Accurate prediction of protein-ligand binding affinities is crucial in drug discovery, particularly during hit-to-lead and lead optimization phases, however, limitations in ligand force fields continue to impact prediction accuracy. In this work, we validate relative binding free energy (RBFE) accuracy using neural network potentials (NNPs) for the ligands. We utilize a novel NNP model, AceForce 1.0, based on the TensorNet architecture for small molecules that broadens the applicability to diverse drug-like compounds, including all important chemical elements and supporting charged molecules. Using established benchmarks, we show overall improved accuracy and correlation in binding affinity predictions compared with GAFF2 for molecular mechanics and ANI2-x for NNPs. Slightly less accuracy but comparable correlations with OPLS4. We also show that we can run the NNP simulations at 2 fs timestep, at least two times larger than previous NNP models, providing significant speed gains. The results show promise for further evolutions of free energy calculations using NNPs while demonstrating its practical use already with the current generation. The code and NNP model are publicly available for research use.
Problem

Research questions and friction points this paper is trying to address.

Drug Discovery
Protein-Ligand Binding
Computational Methods
Innovation

Methods, ideas, or system contributions that make the work stand out.

QuantumBind-RBFE
Neural Network Potential
Drug Discovery Acceleration
🔎 Similar Papers
No similar papers found.
Francesc Sabanés Zariquiey
Francesc Sabanés Zariquiey
Acellera
Computational chemistrymolecular dynamicsComputer aided drug design
S
Stephen E. Farr
Acellera Labs, C Dr Trueta 183, 08005, Barcelona, Spain
Stefan Doerr
Stefan Doerr
Acellera Ltd
Molecular DynamicsMarkov ModelsMachine Learning
G
G. D. Fabritiis
Acellera Therapeutics, 38350 Fremont Blvd 203 Fremont CA, 94536 USA; Computational Science Laboratory, Universitat Pompeu Fabra, Barcelona Biomedical Research Park (PRBB), C Dr. Aiguader 88, 08003, Barcelona, Spain; Institució Catalana de Recerca i Estudis Avançats (ICREA), Passeig Lluis Companys 23, 08010 Barcelona, Spain